Abstract
Recently, published studies have reported conflicting results regarding the association between efavirenz exposure and the risk of suicidality among patients with human immunodeficiency virus. The objective of this analysis was to compare the rate of suicidality among patients initiating efavirenz-containing versus efavirenz-free antiretroviral (ARV) regimens.This retrospective cohort study used US administrative claims data for commercially and Medicaid-insured individuals for the years 2006 to 2013. ARV-naive patients aged ≥12 years initiating an efavirenz-containing or efavirenz-free ARV regimen with ≥6 months of continuous insurance enrollment prior to ARV initiation were selected. The primary outcome was suicidality, defined as the occurrence of any medical claim with a diagnosis code for suicidal ideation or an inpatient or emergency department medical claim for suicide attempt. Unadjusted incidence rates were calculated and propensity score-adjusted hazard ratios were estimated to account for differences in patient characteristics.There were 19,983 patients (efavirenz-containing, n = 11,187; efavirenz-free, n = 8796) in the commercial database and 5154 patients (efavirenz-containing, n = 2224; efavirenz-free, n = 2930) i...Continue Reading
References
Oct 4, 2000·Social Psychiatry and Psychiatric Epidemiology·C IribarrenC Weisner
Jun 11, 2002·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Timothy G HeckmanMonica Silverthorn
Jan 22, 2003·HIV Medicine·P LochetJ Reynes
Jun 17, 2005·Journal of Behavioral Medicine·Nina A Cooperman, Jane M Simoni
Nov 4, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Félix GutiérrezAlberto Martín-Hidalgo
Apr 21, 2006·American Journal of Epidemiology·M Alan BrookhartTil Stürmer
Mar 21, 2007·Expert Opinion on Drug Safety·Gabriele ArendtThorsten Nolting
Oct 6, 2010·Pharmacoepidemiology and Drug Safety·Amanda R PatrickSebastian Schneeweiss
Apr 13, 2011·AIDS and Behavior·Christopher A Kenedi, Harold W Goforth
Jul 13, 2011·Psychology, Health & Medicine·Jose CatalanLorraine Sherr
Jul 26, 2011·Journal of Affective Disorders·Jayraan BadieeIgor Grant
Feb 16, 2013·Pharmacoepidemiology and Drug Safety·S Todd CallahanWilliam O Cooper
Jul 1, 2014·Annals of Internal Medicine·Katie R MollanCamlin Tierney
Sep 7, 2014·Journal of the International AIDS Society·Andrew A NapoliHugh H Tilson
Nov 14, 2014·Journal of the International AIDS Society·Colette SmithJens Lundgren
Sep 22, 2015·CMAJ Open·Jasmine GurmSilvia Guillemi
Citations
Aug 19, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Glenn J Treisman, Olivia Soudry
Aug 9, 2016·Expert Review of Clinical Pharmacology·Johannes P MoutonGary Maartens
May 26, 2017·Journal of the International AIDS Society·Pedro CahnOmar Sued
Oct 9, 2018·CNS Spectrums·Kellie J GoodletAlyssa M Peckham
Mar 19, 2019·Statistics in Medicine·Chenguang Wang, Gary L Rosner
Jun 12, 2019·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceJohn B Wong
Jun 12, 2019·JAMA : the Journal of the American Medical Association·Roger ChouChristina Bougatsos
Jun 28, 2018·Pharmacological Reviews·Dhwanil A DalwadiJohn A Schetz
Jul 28, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Angela M BengtsonMichael J Mugavero
Aug 12, 2016·Pharmacogenetics and Genomics·Paul LegerDavid W Haas
Sep 22, 2017·The Journal of Infectious Diseases·Katie R MollanUNKNOWN AIDS Clinical Trials Group
Mar 15, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alejandro Arenas-PintoUNKNOWN INSIGHT START study group
Jun 28, 2018·Annals of Internal Medicine·Jonathan L ChangMark J Siedner
May 12, 2021·American Journal of Epidemiology·Katie R MollanUNKNOWN CFAR Network of Integrated Clinical Systems and the AIDS Clinical Trials Group